SEC Tracker
Get the app

Quest Diagnostics DGX

Quest Diagnostics announces executive transition

Reports an executive or board change

Form
8-K
Filed
Importance
Major
  1. Catherine T. Doherty to retire in July 2027
  2. Effective November 1, 2026, new role as Executive Vice President
  3. Annual base salary remains $650,000
  4. Equity award of $1.2M in restricted stock units

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Quest Diagnostics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. Labcorp Holdings LH public float $21.7B, Jun 30, 2025
  2. Natera NTRA public float $21.8B, Jun 30, 2025
  3. Exact Sciences EXAS public float $10.0B, Jun 30, 2025
  4. Guardant Health GH public float $6.2B, Jun 30, 2025
  5. RadNet RDNT public float $4.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.